Company: IOBT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058699
Chunk: 28

Company: IO Biotech, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 28
---
 thereafter, subject to the named executive officer’s continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by us without cause and 100% acceleration upon termination of service by us without cause if such termination occurs within 24 months of a change of control of the Company. Claw back Policy The Company maintains a Dodd-Frank Clawback Policy adopted to comply with SEC and Nasdaq listing rules. Under that policy, the Company is required in certain situations to recoup incentive compensation paid or payable to certain current or former executive officers of the Company, including the named executive officers, in the event of an accounting restatement.

<div align='center'>21</div>

2024 Sum mary Compensation Table The following table shows information regarding the compensation of our named executive officers for services performed in the year ended December 31, 2024 and, to the extent required by SEC disclosure rules, December 31, 2023.

| Name and Principal Position(1) |     | Year |     | Salary ($) |         |     | Bonus  
 ($)(2) |        |     | Option 
 Awards 
 ($)(3) |         |     | Non-Equity     
 Incentive Plan 
 Compensation   
 ($)(4)         |         |     | All Other    
 Compensation 
 ($)(5)       |        |     | Total ($) |           |
| Mai-Britt Zocca, Ph.D.,        |     | 2024 |     |            | 567,788 |     |        |      — |     |        | 931,350 |     |                | 283,894 |     |              | 56,779 |     |           | 1,839,811 |
| Chief Executive Officer        
 and Founder                    |     | 2023 |     |            | 540,750 |     |        |      — |     |        | 752,850 |     |                | 297,413 |     |              | 54,075 |     |           | 1,645,088 |
| Qasim Ahmad, M.D.,             |     | 2024 |     |            | 480,000 |     |        |      — |     |        | 347,704 |     |                | 216,000 |     |              | 13,800 |     |           | 1,057,504 |
| Chief Medical Officer          |     | 2023 |     |            | 220